M D12 (Doxazosin 8 mg)
Pill imprint M D12 has been identified as Doxazosin mesylate 8 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M D12 (Doxazosin 8 mg)
- 8 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium lauryl sulfate
sodium starch glycolate type A potato
FD&C Blue No. 2
D&C Red No. 30
|NDC Code||Manufacturer / Repackager|
|67544-0273||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
Doxazosin mesylate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...